UNICEF adds Sinovac to assortment of contracted COVID-19 vaccine suppliers

AFRICA – UNICEF has inked a long-term agreement with Sinovac for the supply of Sinovac Covid-19 vaccine, the CoronaVac inactivated virus vaccine against coronavirus, on behalf of COVAX. This is the 8th supply agreement UNICEF has signed for COVID-19 vaccines. Previous agreements have been announced with the Serum Institute of India, Pfizer, AstraZeneca, Human Vaccine, Moderna, Janssen Pharmaceutica NV and Sinopharm. Through the supply agreement, UNICEF will have access to up to 200 million doses of the vaccine in 2021 to supply participating countries and territories in the COVAX Facility’s Advance Market…

Read More

Sinovac’s antibodies drops below threshold after six months based on study findings

CHINA – According to a lab study, antibodies triggered by Sinovac Biotech’s COVID-19 vaccine declined below a key threshold from around six months after a second dose for most recipients, although a third shot had a strong booster effect. Chinese researchers reported the findings from a study of blood samples from healthy adults aged between 18-59 in a paper published on Sunday, though it was not peer reviewed. Among participants who received two doses, two or four weeks apart, only 16.9% and 35.2% respectively still had neutralizing antibodies above what…

Read More

Mix match for vaccines new trend as Thailand joins bandwagon despite cautionary advice from WHO

WORLD – Mix and match for vaccines is becoming a global trend as various countries are embracing the use of two different vaccines for their citizens. In Thailand, AstraZeneca vaccines are going to be used as a second dose for those who received Sinovac shots as the first dose in a move that is set to improve protection against COVID-19. The move is the first publicly announced mix-and-match of a Chinese vaccine and a Western-developed shot, as a new preliminary Thai study raised doubts about the long-term protection of the…

Read More

GAVI inks deal with Sinopharm and Sinovac to supply vaccines to COVAX

AFRICA – The Vaccine Alliance (GAVI) has announced that it has signed advance purchase agreements with Sinopharm and Sinovac for immediate supply of Sinopharm’s “BBIBP-Corv” vaccine and Sinovac’s “CoronaVac” vaccine to the COVAX facility. COVAX largely ensures adequate and equitable supply of vaccines to Africa. So far, they have managed to supply 25 million cases. Nineteen countries have used more than 80% of their COVAX-supplied doses, while 31 countries have used more than 50%. In the past two weeks, more than 1.6 million doses were delivered to Africa through COVAX.…

Read More

Toll on South African health system as Covid-19 infections rise amid approval of Sinovac vaccine

SOUTH AFRICA – The cumulative number of COVID-19 cases reported in South Africa stands at 2,062,896 with 16,585 new cases reported today. The number of new deaths reported is 333 making the total number of deaths in the country 61,840. The number of recoveries is 1,808,082 with a recovery rate of 87.6%. The health system in Johannesburg, South Africa’s biggest city, being overwhelmed by a massive wave of infections driven by the Delta variant, the winter in the southern hemisphere and a faltering vaccine campaign. The new variant, which is…

Read More